A single administration of 2,3,7,8-tetrachlorodibenzo-p-dioxin that produces reduced food and water intake induces long-lasting expression of corticotropin-releasing factor, arginine vasopressin, and proopiomelanocortin in rat brain

Toxicology and Applied Pharmacology

Volumn 233, Issue 2, 2008, Pages 314-322

  Moon, Bo Hyun ^a   Hong, Chang Gwun ^a   Kim, Soo Young ^a   Kim, Hyun Ju ^a   Shin, Seung Keon ^a   Kang, Seungwoo ^a   Lee, Kuem Ju ^a   Kim, Yong Ku ^a   Lee, Min Soo ^a   Shin, Kyung Ho ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

2,3,7,8 tetrachlorodibenzo p dioxin; Arginine vasopressin; Corticotropin releasing factor; Proopiomelanocortin

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; ARGIPRESSIN; CORTICOTROPIN RELEASING FACTOR; MESSENGER RNA; NEUROPEPTIDE; PROOPIOMELANOCORTIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARCUATE NUCLEUS; ARTICLE; CONTROLLED STUDY; FEEDING; FLUID INTAKE; FOOD INTAKE; GENE EXPRESSION; HYPOTHALAMUS; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; RAT; THALAMUS MIDLINE NUCLEUS;

ANIMALS; ARGININE VASOPRESSIN; CORTICOTROPIN-RELEASING HORMONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRINKING; EATING; ENVIRONMENTAL POLLUTANTS; GENE EXPRESSION REGULATION; HYPOTHALAMUS; MALE; PRO-OPIOMELANOCORTIN; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TETRACHLORODIBENZODIOXIN; TIME FACTORS;

RATTUS;

EID: 56249131070     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2008.09.001     Document Type: Article

References (34)

1. Alonso G., and Assenmacher I. Radioautographic studies on the neurohypophysial projections of the supraoptic and paraventricular nuclei in the rat. Cell Tissue Res. 219 (1981) 525-534
2. Bestervelt L.L., Pitt J.A., and Piper W.N. Evidence for Ah receptor mediation of increased ACTH concentrations in primary cultures of rat anterior pituitary cells exposed to TCDD. Toxicol. Sci. 46 (1998) 294-299
3. Castro M.G., and Morrison E. Post-translational processing of proopiomelanocortin in the pituitary and in the brain. Crit. Rev. Neurobiol. 11 (1997) 35-57
4. Ciccocioppo R., Fedeli A., Economidou D., Policani F., Weiss F., and Massi M. The bed nucleus is a neuroanatomical substrate for the anorectic effect of corticotropin-releasing factor and for its reversal by nociceptin/orphanin FQ. J. Neurosci. 23 (2003) 9445-9451
5. Coll A.P. Effects of pro-opiomelanocortin (POMC) on food intake and body weight: mechanisms and therapeutic potential?. Clin. Sci. (Lond) 113 (2007) 171-182
6. Crespi E.J., Vaudry H., and Denver R.J. Roles of corticotropin-releasing factor, neuropeptide Y and corticosterone in the regulation of food intake in Xenopus laevis. J. Neuroendocrinol. 16 (2004) 279-288
7. de Arruda Camargo L.A., Saad W.A., and Cerri P.S. Effects of V1 and angiotensin receptor subtypes of the paraventricular nucleus on the water intake induced by vasopressin injected into the lateral septal area. Brain Res. Bull. 61 (2003) 481-487
8. Erkut Z.A., Pool C., and Swaab D.F. Glucocorticoids suppress corticotropin-releasing hormone and vasopressin expression in human hypothalamic neurons. J. Clin. Endocrinol. Metab. 83 (1998) 2066-2073
9. Fan W., Boston B.A., Kesterson R.A., Hruby V.J., and Cone R.D. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 385 (1997) 165-168
10. Fetissov S.O., Huang P., Zhang Q., Mimura J., Fujii-Kuriyama Y., Rannug A., Hokfelt T., and Ceccatelli S. Expression of hypothalamic neuropeptides after acute TCDD treatment and distribution of Ah receptor repressor. Regul. Pept. 119 (2004) 113-124
11. Gao Q., and Horvath T.L. Neurobiology of feeding and energy expenditure. Annu. Rev. Neurosci. 30 (2007) 367-398
12. Huang P., Ceccatelli S., Hakansson H., Grandison L., and Rannug A. Constitutive and TCDD-induced expression of Ah receptor-responsive genes in the pituitary. Neurotoxicology 23 (2002) 783-793
13. Kasdallah A.G., Mornagui B., Gharbi N., Machghoul S., and El-Fazaa S. Metabolic and endocrine effects of water and/or food deprivation in rats. C R Biol. 328 (2005) 463-470
14. Kask A., Rago L., Wikberg J.E., and Schioth H.B. Differential effects of melanocortin peptides on ingestive behaviour in rats: evidence against the involvement of MC(3) receptor in the regulation of food intake. Neurosci. Lett. 283 (2000) 1-4
15. Kim H.J., Lee J.H., Choi S.H., Lee Y.S., and Jahng J.W. Fasting-induced increases of arcuate NPY mRNA and plasma corticosterone are blunted in the rat experienced neonatal maternal separation. Neuropeptides 39 (2005) 587-594
16. Krahn D.D., Gosnell B.A., Levine A.S., and Morley J.E. Behavioral effects of corticotropin-releasing factor: localization and characterization of central effects. Brain Res. 443 (1988) 63-69
17. Millington G.W. The role of proopiomelanocortin (POMC) neurones in feeding behaviour. Nutr. Metab. (Lond) 4 (2007) 18
18. Moldow R.L., and Fischman A.J. Physiological changes in rat hypothalamic CRF: circadian, stress and steroid suppression. Peptides 3 (1982) 837-840
19. Moldow R.L., and Fischman A.J. Circadian rhythm of corticotropin releasing factor-like immunoreactivity in rat hypothalamus. Peptides 5 (1984) 1213-1215
20. Morley J.E. Neuropeptide regulation of appetite and weight. Endocr. Rev. 8 (1987) 256-287
21. Ni Y.G., Gold S.J., Iredale P.A., Terwilliger R.Z., Duman R.S., and Nestler E.J. Region-specific regulation of RGS4 (Regulator of G-protein-signaling protein type 4) in brain by stress and glucocorticoids: in vivo and in vitro studies. J. Neurosci. 19 (1999) 3674-3680
22. Ogasa T., Hashimoto K., Suemaru S., Kageyama J., and Ota Z. The magnocellular arginine-vasopressin mRNA responds differently to food deprivation between the supraoptic and paraventricular nuclei of the hypothalamus in adrenalectomized rats with low corticosterone replacement. Brain Res. 583 (1992) 45-53
23. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (1997), Academic Press, San Diego
24. Pohjanvirta R., and Tuomisto J. Short-term toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in laboratory animals: effects, mechanisms, and animal models. Pharmacol. Rev. 46 (1994) 483-549
25. Pohjanvirta R., Tuomisto J., Vartiainen T., and Rozman K. Han/Wistar rats are exceptionally resistant to TCDD. I. Pharmacol. Toxicol. 60 (1987) 145-150
26. Pohjanvirta R., Tuomisto J., and Vikkula K. Screening of pharmacological agents given peripherally with respect to TCDD-induced wasting syndrome in Long-Evans rats. Pharmacol. Toxicol. 63 (1988) 240-247
27. Schwartz M.W., Seeley R.J., Woods S.C., Weigle D.S., Campfield L.A., Burn P., and Baskin D.G. Leptin increases hypothalamic pro-opiomelanocortin mRNA expression in the rostral arcuate nucleus. Diabetes 46 (1997) 2119-2123
28. Shridhar S., Farley A., Reid R.L., Foster W.G., and Van Vugt D.A. The effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on corticotrophin-releasing hormone, arginine vasopressin, and pro-opiomelanocortin mRNA levels in the hypothalamus of the cynomolgus monkey. Toxicol. Sci. 63 (2001) 181-188
29. Szczepanska-Sadowska E., Sobocinska J., and Sadowski B. Central dipsogenic effect of vasopressin. Am. J. Physiol. 242 (1982) R372-R379
30. Tuomisto J., Andrzejewski W., Unkila M., Pohjanvirta R., Linden J., Vartiainen T., and Tuomisto L. Modulation of TCDD-induced wasting syndrome by portocaval anastomosis and vagotomy in Long-Evans and Han/Wistar rats. Eur. J. Pharmacol. 292 (1995) 277-285
31. Unkila M., Tuomisto J.T., Pohjanvirta R., MacDonald E., Tuomisto L., Koulu M., and Tuomisto J. Effect of a single lethal dose of TCDD on the levels of monoamines, their metabolites and tryptophan in discrete brain nuclei and peripheral tissues of Long-Evans rats. Pharmacol. Toxicol. 72 (1993) 279-285
32. van Logten M.J., Gupta B.N., McConnell E.E., and Moore J.A. The influence of malnutrition on the toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in rats. Toxicology 21 (1981) 77-88
33. Zemo D.A., and McCabe J.T. Transcriptional responses of the rat vasopressin gene to acute and repeated acute osmotic stress. Neurosci. Res. 44 (2002) 45-50
34. Zorrilla E.P., Reinhardt L.E., Valdez G.R., Inoue K., Rivier J.E., Vale W.W., and Koob G.F. Human urocortin 2, a corticotropin-releasing factor (CRF)2 agonist, and ovine CRF, a CRF1 agonist, differentially alter feeding and motor activity. J. Pharmacol. Exp. Ther. 310 (2004) 1027-1034